Samlyn Capital’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,463,074
| Closed | -$10M | – | 72 |
|
|
2023
Q3 | $10M | Buy |
1,463,074
+119,005
| +9% | +$815K | 0.16% | 80 |
|
|
2023
Q2 | $13.9M | Buy |
1,344,069
+292,501
| +28% | +$3.03M | 0.24% | 67 |
|
|
2023
Q1 | $8.51M | Buy |
+1,051,568
| New | +$8.51M | 0.15% | 75 |
|
|
2017
Q1 | – | Sell |
-136,000
| Closed | -$3.69M | – | 120 |
|
|
2016
Q4 | $3.69M | Buy |
+136,000
| New | +$3.69M | 0.08% | 109 |
|